Global healthcare M&A doubles versus 2014

LONDON (Reuters) - Worldwide dealmaking in the healthcare sector has doubled this year compared with the same time in 2014, buoyed by Teva Pharmaceuticals Industries' unsolicited $40 billion (26 billion pounds) bid for smaller rival Mylan this week, Thomson Reuters data shows. So far this year, deals worth $193.9 billion have been announced in healthcare, the data shows. Worldwide M&A is up 23 percent year-to-date versus the same period last year, with deals worth $1,186 trillion having been struck so far. (Reporting By Anjuli Davies; Editing by Pravin Char)